 |
 |
|
|
Resources for Food and Drug Administration (FDA)Resources > FDA > ArticlesSub-Categories: Listings 1071 - 1080 of 2187:
FDA Releases Guidelines For Genetically Engineered Animals
The Food and Drug Administration issued on Thursday “The Regulation of Genetically Engineered Animals Containing Heritable rDNA Constructs,” which wil...
FDA releases tidal wave of fresh recalls
Federal officials have released a tidal wave of fresh recalls in the past 24 hours as they connect the dots in the supply chain of tainted peanut-rela...
FDA renews alert on painkiller patch
The government issued a new safety warning Friday for a skin patch containing a potent painkiller that has been implicated in hundreds of deaths, sayi...
FDA repeats warning on OTC cold drugs for kids under 2
The U.S. FDA issued a public health advisory on Thursday, warning parents not to give OTC cold drugs to their children under age 2 "because serious an...
FDA Report Says Agency Cannot Do Its Job
The U.S. Food and Drug Administration regulates most of the food sold in the United States, as well as all drugs, human vaccines and medical devices. ...
FDA reports insulin syringe recall
The FDA announced that Covidien, formerly Tyco Healthcare, recalled one lot of Relion sterile, single-use, disposable, hypodermic syringes with affixe...
FDA reports new deaths with diabetes drug Byetta
Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after d...
FDA reports Salmonella in peanut butter tied to Texas plant
The US Food and Drug Administration (FDA) offered additional evidence today that the Peanut Corp of America (PCA) plant in Blakely, Ga., may not be t...
FDA Reports Side Effects Linked to Wrinkle Fillers
An ugly side of the beauty business emerged today, as an FDA briefing listed 930 reports of side effects for injectable wrinkle fillers such as Restyl...
FDA reprimands GlaxoSmithKline over missing data on rosiglitazone
The Food and Administration (FDA) has reprimanded GlaxoSmithKline (GSK) for failing to report all of its postapproval data on rosiglitazone (Avandia),... |
|
RSS Feeds|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2012 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |
 |
 |